The trial is called EVOLUTION. This trial is adding to Lutetium-177 treatment, two immunotherapy drugs - the checkpoint inhibitors ipilimumab and nivolumab. Immune checkpoints are key regulators of th
Two things I can confirm from experience (high dose rate brachytherapy boost 12 years ago plus lots of hormone therapy): Your 'old fella', even if it does not get stiff, still has all its feeling, and
In a paper about expected survival based on, among other things, average tumor length: "Whereas the median tumor length for Gleason scores 4 through 6 was 2.9 mm, the median length for Gleason scores